Tamtam Try Tamtam free
Moffitt Cancer Center logo

Moffitt Cancer Center account plan

Cancer care and research

At a glance

Moffitt Cancer Center is a Tampa, Florida NCI Comprehensive Cancer Center with 346 licensed beds and $3,016.8 million of FY2025 revenues.

H. Lee Moffitt Cancer Center & Research Institute is a not-for-profit cancer hospital and research institute in Tampa, Florida, created by the Florida Legislature in 1984 and licensed for 346 general acute care beds. It is a National Cancer Institute Comprehensive Cancer Center and an affiliated teaching hospital of the University of South Florida, drawing most patients from the greater Tampa Bay area. In FY2025 (year to June 30, 2025) total revenues and other support were $3,016.8 million, of which patient service revenues were $2,609.5 million, and income from operations was $127.5 million. It also receives State of Florida appropriations of about $60.2 million a year and a 10% share of Florida cigarette tax collections.

Business units

Strategic priorities

Research-led cancer care
The mission is to contribute to the prevention and cure of cancer; CEO Patrick Hwu frames Moffitt as driving the research that will define the future of care.
Pasco County development
Bond proceeds fund research buildings, proton therapy centers, ambulatory clinics and other capital expenses of the new development in Pasco County, Florida.
Capacity expansion
Purchases of property, plant and equipment reached $318.2 million in FY2025 against $172.4 million in FY2024, with about $380.2 million of remaining estimated costs on projects under way or planned.
Mission-driven organization
The CEO wants every part of the organization, from the lab and bedside to operations, to be mission-driven, and leads by listening to senior leaders and front-line nurses.
Commercializing research
Intellectual property developed by the Cancer Center is commercialized through the for-profit Moffitt Technologies Corporation.

Investments and deals

Capital programme
$318.2 million of property, plant and equipment purchases in FY2025; construction in progress rose to $311.1 million from $201.4 million.
2023A Cigarette Tax bonds
$325.9 million issued in March 2023 for research buildings, proton therapy centers, Moffitt Ambulatory Clinics and the Pasco County development.
2023B Hospital Revenue Bonds
$200 million issued in September 2023 to fund capital projects; long-term debt totalled $1,153.8 million at June 30, 2025.

Challenges and risks

Reimbursement complexity
Medicare and Medicaid rules are described as extremely complex, with a reasonable possibility that recorded estimates change by a material amount.
Payor and regional concentration
Managed care payors account for 79% of patient service revenue and most patients come from the greater Tampa Bay area.
Rising supply costs
Supplies grew to $1,108.6 million in FY2025 from $905.5 million in FY2024.
Dependence on State support
State appropriations and Cigarette Tax funds are subject to future legislative support, and grant funding is subject to agency audits.

What leadership says

“At places like Moffitt, we don't just treat cancer, we are driving the research that will define the future of care. And right now, it's the time to put the pedal to the metal.”

Patrick Hwu, MD, President and CEO · InterView: Patrick Hwu, MD, Tampa Magazine, July 15, 2025

“My business philosophy is centered around ensuring that every part of the organization is mission-driven.”

Patrick Hwu, MD, President and CEO · InterView: Patrick Hwu, MD, Tampa Magazine, July 15, 2025

Where a supplier can help

Construction and facility fit-out
About $380.2 million of remaining project costs, including research buildings, proton therapy centers and ambulatory clinics in Pasco County, create demand for construction, medical equipment and facility services.
Supply chain cost control
Supplies spend rising to $1,108.6 million makes procurement, pharmacy and inventory optimization a relevant topic.
Revenue cycle and reimbursement
Complex Medicare and Medicaid rules and heavy reliance on managed care payors point to revenue-cycle, coding and payer-contracting support.
Research operations and IP commercialization
The research-led priority and Moffitt Technologies Corporation open room for clinical research platforms, data tools and technology-transfer services.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Moffitt Cancer Center?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Moffitt Cancer Center

What is Moffitt Cancer Center?

A not-for-profit cancer hospital and research institute in Tampa, Florida, designated a National Cancer Institute Comprehensive Cancer Center and licensed for 346 general acute care beds.

What is Moffitt's revenue?

Total revenues and other support were $3,016.8 million in FY2025 (year to June 30, 2025), including $2,609.5 million of patient service revenues.

What is Moffitt investing in?

Research buildings, proton therapy centers, ambulatory clinics and a new development in Pasco County, Florida, funded largely by bonds.

Who leads Moffitt Cancer Center?

Patrick Hwu, MD, a tumor immunologist who helped pioneer CAR T-cell therapy, is President and CEO.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)